Careers

Contact Us

About Us

Home

News

  Introduction      |       Products       |      Applications       |       Partnering       |       Events    

More >>

CPI Supports GlycoSeLect to Develop High Throughput Glycan Analysis Platform for Biotherapeutics

GlycoSeLect team is pleased to share the news that CPI used GSL RPL technology and ForteBio biosensor technology to create a rapid and high throughput innovative glycan analysis platform.​

News October 2017: ​​GlycoSeLect Completes 450K Seed Funding Round                   More >>

News August 2016: ​​GSL UK  Announces Establishment of a New Research Laboratory in South Tees Bio-Incubator                   ​More >>

News Jan 2017: Silicon Republic - Innovation: GlycoSeLect Listed as One of "10 Marvellous Medtec Start-Ups You Need to Know" ​​More >>               

Latest News: October 24th 2017

RPLs present many Advantages over existing analytical and purification tools. RPL production is also readily scalable enabling their use for all application scales.​​

​RPLs are enhanced glycoselective bioaffinity proteins that enable efficient detection, analysis and selective isolation of glycosylated biomolecules. Applications​

GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs). ​​

       Introduction     |        Products        |      Applications      |        Partnering       |      Events 

Recombinant Prokaryotic Lectins